Taken together, our research has proposed that DSS can alleviate TGF-β1 – and BLM-induced PF via inhibiting the conversion of fibroblasts to myofibroblasts, possibly through suppressing the MEK/ERK signaling pathway. The gene discussed is MAP2K7; the disease is Bloom syndrome.